10 CFR 26.123, Testing Facility Capabilities: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by Mark Hawes)
 
(No difference)

Latest revision as of 18:19, 25 November 2014

Testing facility capabilities Each licensee testing facility shall have the capability, at the same premises, to perform either validity screening tests or initial validity tests or both, and initial drug tests for each drug and drug metabolite for which testing is conducted.

Federal Register

"[FR" contains a listed "[" character as part of the property label and has therefore been classified as invalid.]


External Links

NRC website 10 CFR 26.123